Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FOXTONS GROUP PLC Director's Dealing 2019

Dec 5, 2019

5323_dirs_2019-12-05_dc44b462-200a-4332-8192-13013363c4c3.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8396V

Foxtons Group PLC

05 December 2019

Foxtons Group plc

("Foxtons" or the "Company")

Director Declaration

The Company announces that Garry Watts, Non-Executive Chairman of the Company, will be appointed as a non-executive director and senior independent director of Circassia Pharmaceuticals plc, a company listed on AlM, with effect from 2 March 2020.

This announcement is made in accordance with Listing Rule 9.6.14.

5 December 2019

For further information please contact:

Foxtons Group plc
Chris Hough, Company Secretary

Muhammed Patel, Investor Relations
+44 20 7893 6261

LEI: 5493001HCMG6R1MYKC59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RDNGMMGZMKNGLZM